The Dual Roles of NRF2 in Cancer

氧化应激 癌症 癌症研究 基因沉默 表观遗传学 生物 KEAP1型 癌细胞 细胞生物学 转录因子 生物化学 遗传学 基因
作者
Silvia Menegon,Amedeo Columbano,Silvia Giordano
出处
期刊:Trends in Molecular Medicine [Elsevier BV]
卷期号:22 (7): 578-593 被引量:564
标识
DOI:10.1016/j.molmed.2016.05.002
摘要

Under homeostatic conditions, NRF2 activation prevents excessive cellular damage produced by metabolic, xenobiotic, and oxidative stress. NRF2 activation is thus important in cancer chemoprevention. Nrf2-null mice are more prone to develop cancer in response to chemical and physical stimuli (nitrosamine, ultraviolet light, aflatoxin). NRF2 hyperactivation confers several advantages to cancer cells, including protection from apoptosis and senescence, promotion of cell growth, and resistance to chemo- and radiotherapy. In experimental models, Nrf2/Keap1 mutations are present at pre-neoplastic stages. Distinct mechanisms are responsible for NRF2 activation in cancer, including (i) somatic mutations in NRF2 or KEAP1, (ii) epigenetic silencing of the KEAP1 promoter, (iii) microRNA-mediated regulation of NRF2 and KEAP1, (iv) aberrant accumulation of proteins that disrupt the interaction between NRF2 and KEAP1, (v) interaction with other ‘cancer master players’, and (vi) metabolic modifications. NRF2 has been traditionally considered as a tumor suppressor because its cytoprotective functions are deemed to be the main cellular defense mechanism against exogenous and endogenous insults, including xenobiotics and oxidative stress. However, several recent studies demonstrate that hyperactivation of the NRF2 pathway creates an environment that favors the survival of normal as well as malignant cells, protecting them against oxidative stress, chemotherapeutic agents, and radiotherapy. In a rapidly advancing field, this review summarizes some of the known mechanisms by which NRF2 can exert its oncogenic functions, and describes the current status of NRF2 inhibitors, providing a clear rationale for the consideration of NRF2 as a powerful putative therapeutic target in cancer treatment. NRF2 has been traditionally considered as a tumor suppressor because its cytoprotective functions are deemed to be the main cellular defense mechanism against exogenous and endogenous insults, including xenobiotics and oxidative stress. However, several recent studies demonstrate that hyperactivation of the NRF2 pathway creates an environment that favors the survival of normal as well as malignant cells, protecting them against oxidative stress, chemotherapeutic agents, and radiotherapy. In a rapidly advancing field, this review summarizes some of the known mechanisms by which NRF2 can exert its oncogenic functions, and describes the current status of NRF2 inhibitors, providing a clear rationale for the consideration of NRF2 as a powerful putative therapeutic target in cancer treatment. a carcinogenic mycotoxin produced by fungi (mainly Aspergillus) that causes mutations through binding of its metabolites to DNA. nutrient generated from vitamin A that helps cells to grow and develop, especially in the embryo. ATRA binds to and activates retinoic acid receptors (RARs), thereby inducing changes in gene expression that lead to cell differentiation and decreased cell proliferation. natural, destructive mechanism that disassembles, through a regulated process, unnecessary or dysfunctional cellular components. Autophagy allows the orderly degradation and recycling of cellular components. B-RAF encodes a serine/threonine protein kinase that is part of the RAS–MAPK signaling cascade. the use of natural, synthetic, or biological substances, food supplements, or other agents in the diet to inhibit the development or progression of malignant changes in cells. short stretches of DNA in which the frequency of the CG sequence is higher than in other regions. The ‘p’ in CpG indicates that ‘C’ and ‘G’ are connected by a phosphodiester bond. represses transcription when tethered to a promoter and plays a key role in transcriptional regulation, cell cycle progression, and developmental events. c-JUN, in combination with c-FOS, forms the AP-1 early response transcription factor. MYC is a transcription factor that activates expression of many genes through binding enhancer box sequences (E-boxes) and recruiting histone acetyltransferases (HATs). a GTPase that recruits and activates proteins, such as c-RAF and PI3K, that are necessary for the propagation of receptor signals. an imbalance between the generation of reactive oxygen metabolites (free radicals) and antioxidant defense mechanisms. a metabolic pathway parallel to glycolysis that generates NADPH and pentoses as well as ribose 5-phosphate, a precursor of nucleotide synthesis. enzymes engaged in biotransformation (through conjugating reactions of endogenous compounds and xenobiotics to more easily excretable forms), as well as in the metabolic inactivation of pharmacologically active substances. the signaling network defined by PI3K, AKT, and the mechanistic target of rapamycin (mTOR) which controls most hallmarks of cancer. The pathway also contributes to cancer-promoting aspects of the tumor environment such as angiogenesis and inflammatory cell recruitment. a family of protein kinase enzymes involved in controlling the function of other proteins through the phosphorylation of hydroxyl groups of serine and threonine amino acid residues on those proteins. immature red blood cells (typically 1% of red blood cells in humans) that still harbor some RNAs and mitochondria. a blood disorder due to a genetic alteration of hemoglobin. This leads to rigid, sickle-like shaped dysfunctional erythrocytes. foreign chemicals or natural compounds that include carcinogens, drugs, drug metabolites, and environmental compounds such as pollutants, synthetic pesticides, and herbicides. the phenomenon by which most cancer cells predominantly produce energy by a high rate of glycolysis instead of by mitochondrial pyruvate oxidation as in most normal cells.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
瑾瑜完成签到,获得积分10
1秒前
文小杰完成签到,获得积分10
1秒前
山月完成签到,获得积分10
2秒前
CodeCraft应助研友_LOK59L采纳,获得10
2秒前
2秒前
3秒前
欣慰妙海完成签到 ,获得积分20
3秒前
CodeCraft应助zhaopeipei采纳,获得10
3秒前
LIUYONG发布了新的文献求助10
4秒前
lin发布了新的文献求助10
6秒前
7秒前
九湖夷上完成签到 ,获得积分10
7秒前
噼里啪啦完成签到 ,获得积分10
8秒前
大个应助hahaha123213123采纳,获得30
8秒前
8秒前
惊天大幂幂完成签到,获得积分10
8秒前
英姑应助Fang Xianxin采纳,获得10
9秒前
宋老师发布了新的文献求助30
9秒前
王洋完成签到,获得积分10
10秒前
lw777完成签到,获得积分20
10秒前
慢慢完成签到,获得积分10
10秒前
11秒前
靖123456发布了新的文献求助10
11秒前
拓跋箴完成签到,获得积分10
11秒前
彭于晏应助zy采纳,获得10
12秒前
精明玲完成签到 ,获得积分10
13秒前
13秒前
乐乐完成签到,获得积分10
14秒前
VirSnorlax完成签到,获得积分10
14秒前
SciGPT应助LL采纳,获得10
14秒前
妖孽宇发布了新的文献求助10
15秒前
aa完成签到,获得积分20
15秒前
aaaa完成签到,获得积分10
15秒前
马香芦完成签到,获得积分10
16秒前
西红柿完成签到,获得积分10
17秒前
18秒前
懵懂的冬灵完成签到,获得积分10
18秒前
碧蓝可仁完成签到 ,获得积分10
19秒前
王拉拉完成签到 ,获得积分10
19秒前
西西完成签到,获得积分10
19秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
Research on Disturbance Rejection Control Algorithm for Aerial Operation Robots 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038388
求助须知:如何正确求助?哪些是违规求助? 3576106
关于积分的说明 11374447
捐赠科研通 3305798
什么是DOI,文献DOI怎么找? 1819322
邀请新用户注册赠送积分活动 892672
科研通“疑难数据库(出版商)”最低求助积分说明 815029